OrbiMed’s Natus Medical Inc NTUS Stock Holding History

OrbiMed’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-1,427,000	Closed	-$19.5M	–	138
2013 Q2	$19.5M	Buy	+1,427,000	New	+$19.4M	0.41%	48

Other funds holding NTUS

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCM

Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed's NTUS Position: Q3 2013 in Review

OrbiMed sold out of Natus Medical Inc (NTUS) in Q3 2013, closing a stake of 1,427,000 shares — an estimated $19.5M sold.

OrbiMed first reported a position in NTUS in Q2 2013 and held it in 1 quarter. The position peaked at $19.5M in Q2 2013. 133 funds tracked by Wall St. Rank hold NTUS as of Q3 2013.

OrbiMed reported no remaining Natus Medical Inc position as of Q3 2013 after selling out during the quarter.
OrbiMed sold 1,427,000 Natus Medical Inc shares in Q3 2013, an estimated $19.5M.
OrbiMed first reported a position in Natus Medical Inc in Q2 2013 and held it in 1 quarter.
OrbiMed's Natus Medical Inc position peaked at $19.5M in Q2 2013.
133 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2013.

Based on OrbiMed's 13F filing for Q3 2013, filed 14 Nov 2013.